These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

192 related items for PubMed ID: 19200788

  • 1. Inhibitory effect of Cyclosporin A and corticosteroids on the production of IFN-gamma and IL-17 by T cells in Vogt-Koyanagi-Harada syndrome.
    Liu X, Yang P, Lin X, Ren X, Zhou H, Huang X, Chi W, Kijlstra A, Chen L.
    Clin Immunol; 2009 May; 131(2):333-42. PubMed ID: 19200788
    [Abstract] [Full Text] [Related]

  • 2. Diminished frequency and function of CD4+CD25high regulatory T cells associated with active uveitis in Vogt-Koyanagi-Harada syndrome.
    Chen L, Yang P, Zhou H, He H, Ren X, Chi W, Wang L, Kijlstra A.
    Invest Ophthalmol Vis Sci; 2008 Aug; 49(8):3475-82. PubMed ID: 18421089
    [Abstract] [Full Text] [Related]

  • 3. IL-23 promotes CD4+ T cells to produce IL-17 in Vogt-Koyanagi-Harada disease.
    Chi W, Yang P, Li B, Wu C, Jin H, Zhu X, Chen L, Zhou H, Huang X, Kijlstra A.
    J Allergy Clin Immunol; 2007 May; 119(5):1218-24. PubMed ID: 17335887
    [Abstract] [Full Text] [Related]

  • 4. Decreased interleukin-37 expression in Vogt-Koyanagi-Harada disease and upregulation following immunosuppressive treatment.
    Ye Z, Wang C, Tang J, Zhou Y, Bai L, Liu Y, Kijlstra A, Yang P.
    J Interferon Cytokine Res; 2015 Apr; 35(4):265-72. PubMed ID: 25343528
    [Abstract] [Full Text] [Related]

  • 5. Inhibitory effect of rapamycin and dexamethasone on production of IL-17 and IFN-gamma in Vogt-Koyanagi-Harada patients.
    Yang K, Wen J, Liu X, Kijlstra A, Chen L, Chi W, Zhou H, Huang X, Yang P.
    Br J Ophthalmol; 2009 Feb; 93(2):249-53. PubMed ID: 19019941
    [Abstract] [Full Text] [Related]

  • 6. Cytokine profiles in aqueous humor of patients with different clinical entities of endogenous uveitis.
    El-Asrar AM, Struyf S, Kangave D, Al-Obeidan SS, Opdenakker G, Geboes K, Van Damme J.
    Clin Immunol; 2011 May; 139(2):177-84. PubMed ID: 21334264
    [Abstract] [Full Text] [Related]

  • 7. Cyclosporin A inhibits the production of IL-17 by memory Th17 cells from healthy individuals and patients with rheumatoid arthritis.
    Zhang C, Zhang J, Yang B, Wu C.
    Cytokine; 2008 Jun; 42(3):345-52. PubMed ID: 18424069
    [Abstract] [Full Text] [Related]

  • 8. T-cell recognition and cytokine profile induced by melanocyte epitopes in patients with HLA-DRB1*0405-positive and -negative Vogt-Koyanagi-Harada uveitis.
    Damico FM, Cunha-Neto E, Goldberg AC, Iwai LK, Marin ML, Hammer J, Kalil J, Yamamoto JH.
    Invest Ophthalmol Vis Sci; 2005 Jul; 46(7):2465-71. PubMed ID: 15980237
    [Abstract] [Full Text] [Related]

  • 9. Decreased IL-27 expression in association with an increased Th17 response in Vogt-Koyanagi-Harada disease.
    Wang C, Tian Y, Lei B, Xiao X, Ye Z, Li F, Kijlstra A, Yang P.
    Invest Ophthalmol Vis Sci; 2012 Jul 10; 53(8):4668-75. PubMed ID: 22669715
    [Abstract] [Full Text] [Related]

  • 10. Increased IL-7 expression in Vogt-Koyanagi-Harada disease.
    Yang Y, Xiao X, Li F, Du L, Kijlstra A, Yang P.
    Invest Ophthalmol Vis Sci; 2012 Feb 27; 53(2):1012-7. PubMed ID: 22247488
    [Abstract] [Full Text] [Related]

  • 11. Vogt-koyanagi-harada syndrome.
    Fang W, Yang P.
    Curr Eye Res; 2008 Jul 27; 33(7):517-23. PubMed ID: 18600484
    [Abstract] [Full Text] [Related]

  • 12. Critical involvement of IL-12 in IFN-gamma induction by calcineurin antagonists in activated human lymphocytes.
    Wittmann M, Killig C, Bruder M, Gutzmer R, Werfel T.
    J Leukoc Biol; 2006 Jul 27; 80(1):75-86. PubMed ID: 16641133
    [Abstract] [Full Text] [Related]

  • 13. Fetal BM-derived mesenchymal stem cells promote the expansion of human Th17 cells, but inhibit the production of Th1 cells.
    Guo Z, Zheng C, Chen Z, Gu D, Du W, Ge J, Han Z, Yang R.
    Eur J Immunol; 2009 Oct 27; 39(10):2840-9. PubMed ID: 19637224
    [Abstract] [Full Text] [Related]

  • 14. Leptin increases in Vogt-Koyanagi-Harada (VKH) disease and promotes cell proliferation and inflammatory cytokine secretion.
    Liu L, Yang P, He H, Lin X, Jiang L, Chi W, Zhao C, Zhou H.
    Br J Ophthalmol; 2008 Apr 27; 92(4):557-61. PubMed ID: 18245271
    [Abstract] [Full Text] [Related]

  • 15. Elevated serum IL-23 correlates with intraocular inflammation after cataract surgery in patients with Vogt-Koyanagi-Harada disease.
    Jiang S, Liu X, Luo L, Qu B, Huang X, Xu L, Lin Y, Ye S, Liu Y.
    Br J Ophthalmol; 2010 Aug 27; 94(8):1078-82. PubMed ID: 19910285
    [Abstract] [Full Text] [Related]

  • 16. Upregulated IL-23 and IL-17 in Behçet patients with active uveitis.
    Chi W, Zhu X, Yang P, Liu X, Lin X, Zhou H, Huang X, Kijlstra A.
    Invest Ophthalmol Vis Sci; 2008 Jul 27; 49(7):3058-64. PubMed ID: 18579762
    [Abstract] [Full Text] [Related]

  • 17. Inhibition of proinflammatory cytokine by IL-25 in Vogt-Koyanagi-Harada syndrome.
    Xu M, Wang C, Tian Y, Kijlstra A, Yang P.
    Ocul Immunol Inflamm; 2014 Aug 27; 22(4):294-9. PubMed ID: 24329541
    [Abstract] [Full Text] [Related]

  • 18. Prostaglandin E2 enhances Th17 responses via modulation of IL-17 and IFN-gamma production by memory CD4+ T cells.
    Napolitani G, Acosta-Rodriguez EV, Lanzavecchia A, Sallusto F.
    Eur J Immunol; 2009 May 27; 39(5):1301-12. PubMed ID: 19384872
    [Abstract] [Full Text] [Related]

  • 19. Interleukin-17 gene polymorphism is associated with Vogt-Koyanagi-Harada syndrome but not with Behçet's disease in a Chinese Han population.
    Shu Q, Yang P, Hou S, Li F, Chen Y, Du L, Jiang Z.
    Hum Immunol; 2010 Oct 27; 71(10):988-91. PubMed ID: 20620187
    [Abstract] [Full Text] [Related]

  • 20. Dominance of activated T cells and interleukin-6 in aqueous humor in Vogt-Koyanagi-Harada disease.
    Norose K, Yano A, Wang XC, Tokushima T, Umihira J, Seki A, Nohara M, Segawa K.
    Invest Ophthalmol Vis Sci; 1994 Jan 27; 35(1):33-9. PubMed ID: 8300361
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.